论文部分内容阅读
目的:分析血液灌流结合血液透析治疗尿毒症脑病的临床治疗效果。方法:选取我院2013年5月至2014年5收治的尿毒症脑病患者70例作为研究对象,将其随机分成观察组和对照组,每组各35例,对照组进行血液透析治疗,观察组在对照组基础上结合血液灌流治疗,比较两组患者治疗后肌酐、钾离子和钠离子含量变化。结果:经治疗后,观察组肌酐水平要明显低于对照组,差异具有统计学意义(P<0.05);观察组钾离子和钠离子水平明显低于对照组,差异具有统计学意义(P<0.05);观察组治疗总有效率明显高于对照组,差异具有统计学意义(P<0.05)。结论:血液灌流结合血液透析治疗尿毒症脑病的临床治疗效果显著,可以在临床上推广和使用。
Objective: To analyze the therapeutic effect of hemoperfusion combined with hemodialysis on uremic encephalopathy. Methods: Seventy patients with uremic encephalopathy admitted from May 2013 to May 2014 in our hospital were selected as study subjects. They were randomly divided into observation group and control group, with 35 cases in each group. The control group was treated with hemodialysis. The observation group On the basis of the control group combined with hemoperfusion, the changes of creatinine, potassium and sodium in the two groups were compared. Results: After treatment, the creatinine level in the observation group was significantly lower than that in the control group (P <0.05). The levels of potassium and sodium in the observation group were significantly lower than those in the control group (P < 0.05). The total effective rate of observation group was significantly higher than that of control group, the difference was statistically significant (P <0.05). Conclusion: The therapeutic effect of hemoperfusion combined with hemodialysis on uremic encephalopathy is significant and can be popularized and used clinically.